Global Digital PCR and Real-time PCR Market
Global Digital PCR and Real-time PCR Market

Digital PCR and Real-time PCR Comprehensive Study by Type (Instruments, Reagents), Application (Clinical (Pathogen Testing, Blood Screening, Oncology Testing, Others), Research, Forensic and Others), End-user (Hospitals, Diagnostic Labs, Academia, Pharma-Biotech, CRO), Solution (Software, Services) Players and Region - Global Market Outlook to 2024

Digital PCR and Real-time PCR Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

May 2019 Edition 226 Pages 186 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study
Digital PCR (dPCR) counts individual molecules for absolute quantification by dividing a sample into many individual real-time PCR reactions. Digital PCR and real-time PCR market have high growth prospects owing to growing healthcare infrastructure and increasing demand from the developing economies. Further, emphasizing on the development of portable and compact PCR devices and technological advancement expected to drive the demand for digital PCR and real-time PCR market over the forecasted period.

The market study is being classified by Type (Instruments and Reagents), by Application (Clinical [Pathogen Testing, Blood Screening, Oncology Testing, Others], Research and Forensic and Others) and major geographies with country level break-up.

Thermo Fisher Scientific, Inc. (United States), F. Hoffman-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (United States), QIAGEN N.V. (Germany), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (United States), BioMérieux S.A. (France), Fluidigm Corporation (United States), Danaher Corporation (United States), Abbott Laboratories (United States), Merck KGaA (Germany) and Becton Dickinson and Company (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Promega Corporation (United States), Eppendorf AG (Germany) and Analytik Jena AG (Germany).

Leading global players are focusing on strategic partnerships to improve their products. In addition, companies are focusing on increasing their client base to strengthen market position and to enhance product offerings. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Digital PCR and Real-time PCR market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Digital PCR and Real-time PCR market by Type, Application and Region.

On the basis of geography, the market of Digital PCR and Real-time PCR has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End-user, the sub-segment i.e. Hospitals will boost the Digital PCR and Real-time PCR market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Solution, the sub-segment i.e. Software will boost the Digital PCR and Real-time PCR market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Growing Prevalence of Genetic Disorders
  • Government Initiatives for Human Genome Project

Market Trend
  • Emphasizing On Development of Portable and Compact PCR Devices
  • Technological Advancement in the PCR Devices

Restraints
  • High Cost Associated With Digital PCR and Real-Time PCR
  • Stringent Government Regulations Regarding PCR Devices

Opportunities
  • Increasing Demand for Plant Derived To Genome-Based Drug Discovery
  • Growing Healthcare Infrastructure in the Developing Economies

Challenges
  • Lack of Advanced Medical in Facilities in the Emerging Economies



“PCR/qPCR/dPCR Assay Design, assays that are used in regulated environments must be taken through analytical validation and documentation in accordance with ICH guidelines that are recommended for adoption by the regulatory bodies of the European Union, Japan and USA6 for registration of pharmaceuticals for human use.”

Key Target Audience
Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Forensic Laboratories and Others

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Instruments
  • Reagents
By Application
  • Clinical [Pathogen Testing, Blood Screening, Oncology Testing, Others]
  • Research
  • Forensic and Others
By End-user
  • Hospitals
  • Diagnostic Labs
  • Academia
  • Pharma-Biotech
  • CRO

By Solution
  • Software
  • Services

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Prevalence of Genetic Disorders
      • 3.2.2. Government Initiatives for Human Genome Project
    • 3.3. Market Challenges
      • 3.3.1. Lack of Advanced Medical in Facilities in the Emerging Economies
    • 3.4. Market Trends
      • 3.4.1. Emphasizing On Development of Portable and Compact PCR Devices
      • 3.4.2. Technological Advancement in the PCR Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Digital PCR and Real-time PCR, by Type, Application, End-user, Solution and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Digital PCR and Real-time PCR (Value)
      • 5.2.1. Global Digital PCR and Real-time PCR by: Type (Value)
        • 5.2.1.1. Instruments
        • 5.2.1.2. Reagents
      • 5.2.2. Global Digital PCR and Real-time PCR by: Application (Value)
        • 5.2.2.1. Clinical [Pathogen Testing, Blood Screening, Oncology Testing, Others]
        • 5.2.2.2. Research
        • 5.2.2.3. Forensic and Others
      • 5.2.3. Global Digital PCR and Real-time PCR by: End-user (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Diagnostic Labs
        • 5.2.3.3. Academia
        • 5.2.3.4. Pharma-Biotech
        • 5.2.3.5. CRO
      • 5.2.4. Global Digital PCR and Real-time PCR by: Solution (Value)
        • 5.2.4.1. Software
        • 5.2.4.2. Services
      • 5.2.5. Global Digital PCR and Real-time PCR Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Digital PCR and Real-time PCR (Volume)
      • 5.3.1. Global Digital PCR and Real-time PCR by: Type (Volume)
        • 5.3.1.1. Instruments
        • 5.3.1.2. Reagents
      • 5.3.2. Global Digital PCR and Real-time PCR by: Application (Volume)
        • 5.3.2.1. Clinical [Pathogen Testing, Blood Screening, Oncology Testing, Others]
        • 5.3.2.2. Research
        • 5.3.2.3. Forensic and Others
      • 5.3.3. Global Digital PCR and Real-time PCR by: End-user (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Diagnostic Labs
        • 5.3.3.3. Academia
        • 5.3.3.4. Pharma-Biotech
        • 5.3.3.5. CRO
      • 5.3.4. Global Digital PCR and Real-time PCR by: Solution (Volume)
        • 5.3.4.1. Software
        • 5.3.4.2. Services
      • 5.3.5. Global Digital PCR and Real-time PCR Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Digital PCR and Real-time PCR (Price)
      • 5.4.1. Global Digital PCR and Real-time PCR by: Type (Price)
  • 6. Digital PCR and Real-time PCR: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. F. Hoffman-La Roche Ltd. (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. QIAGEN N.V. (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Takara Bio, Inc. (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Agilent Technologies, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BioMérieux S.A. (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Fluidigm Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Danaher Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Abbott Laboratories (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Merck KGaA (Germany)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Becton Dickinson and Company (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Digital PCR and Real-time PCR Sale, by Type, Application, End-user, Solution and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Digital PCR and Real-time PCR (Value)
      • 7.2.1. Global Digital PCR and Real-time PCR by: Type (Value)
        • 7.2.1.1. Instruments
        • 7.2.1.2. Reagents
      • 7.2.2. Global Digital PCR and Real-time PCR by: Application (Value)
        • 7.2.2.1. Clinical [Pathogen Testing, Blood Screening, Oncology Testing, Others]
        • 7.2.2.2. Research
        • 7.2.2.3. Forensic and Others
      • 7.2.3. Global Digital PCR and Real-time PCR by: End-user (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Diagnostic Labs
        • 7.2.3.3. Academia
        • 7.2.3.4. Pharma-Biotech
        • 7.2.3.5. CRO
      • 7.2.4. Global Digital PCR and Real-time PCR by: Solution (Value)
        • 7.2.4.1. Software
        • 7.2.4.2. Services
      • 7.2.5. Global Digital PCR and Real-time PCR Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Digital PCR and Real-time PCR (Volume)
      • 7.3.1. Global Digital PCR and Real-time PCR by: Type (Volume)
        • 7.3.1.1. Instruments
        • 7.3.1.2. Reagents
      • 7.3.2. Global Digital PCR and Real-time PCR by: Application (Volume)
        • 7.3.2.1. Clinical [Pathogen Testing, Blood Screening, Oncology Testing, Others]
        • 7.3.2.2. Research
        • 7.3.2.3. Forensic and Others
      • 7.3.3. Global Digital PCR and Real-time PCR by: End-user (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Diagnostic Labs
        • 7.3.3.3. Academia
        • 7.3.3.4. Pharma-Biotech
        • 7.3.3.5. CRO
      • 7.3.4. Global Digital PCR and Real-time PCR by: Solution (Volume)
        • 7.3.4.1. Software
        • 7.3.4.2. Services
      • 7.3.5. Global Digital PCR and Real-time PCR Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Digital PCR and Real-time PCR (Price)
      • 7.4.1. Global Digital PCR and Real-time PCR by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Digital PCR and Real-time PCR: by Type(USD Million)
  • Table 2. Digital PCR and Real-time PCR Instruments , by Region USD Million (2013-2018)
  • Table 3. Digital PCR and Real-time PCR Reagents , by Region USD Million (2013-2018)
  • Table 4. Digital PCR and Real-time PCR: by Application(USD Million)
  • Table 5. Digital PCR and Real-time PCR Clinical [Pathogen Testing, Blood Screening, Oncology Testing, Others] , by Region USD Million (2013-2018)
  • Table 6. Digital PCR and Real-time PCR Research , by Region USD Million (2013-2018)
  • Table 7. Digital PCR and Real-time PCR Forensic and Others , by Region USD Million (2013-2018)
  • Table 8. Digital PCR and Real-time PCR: by End-user(USD Million)
  • Table 9. Digital PCR and Real-time PCR Hospitals , by Region USD Million (2013-2018)
  • Table 10. Digital PCR and Real-time PCR Diagnostic Labs , by Region USD Million (2013-2018)
  • Table 11. Digital PCR and Real-time PCR Academia , by Region USD Million (2013-2018)
  • Table 12. Digital PCR and Real-time PCR Pharma-Biotech , by Region USD Million (2013-2018)
  • Table 13. Digital PCR and Real-time PCR CRO , by Region USD Million (2013-2018)
  • Table 14. Digital PCR and Real-time PCR: by Solution(USD Million)
  • Table 15. Digital PCR and Real-time PCR Software , by Region USD Million (2013-2018)
  • Table 16. Digital PCR and Real-time PCR Services , by Region USD Million (2013-2018)
  • Table 17. South America Digital PCR and Real-time PCR, by Country USD Million (2013-2018)
  • Table 18. South America Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 19. South America Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 20. South America Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 21. South America Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 22. Brazil Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 23. Brazil Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 24. Brazil Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 25. Brazil Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 26. Argentina Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 27. Argentina Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 28. Argentina Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 29. Argentina Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 30. Rest of South America Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 31. Rest of South America Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 32. Rest of South America Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 33. Rest of South America Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 34. Asia Pacific Digital PCR and Real-time PCR, by Country USD Million (2013-2018)
  • Table 35. Asia Pacific Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 36. Asia Pacific Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 37. Asia Pacific Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 38. Asia Pacific Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 39. China Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 40. China Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 41. China Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 42. China Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 43. Japan Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 44. Japan Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 45. Japan Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 46. Japan Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 47. India Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 48. India Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 49. India Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 50. India Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 51. South Korea Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 52. South Korea Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 53. South Korea Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 54. South Korea Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 55. Taiwan Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 56. Taiwan Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 57. Taiwan Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 58. Taiwan Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 59. Australia Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 60. Australia Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 61. Australia Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 62. Australia Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 63. Rest of Asia-Pacific Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 64. Rest of Asia-Pacific Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 65. Rest of Asia-Pacific Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 66. Rest of Asia-Pacific Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 67. Europe Digital PCR and Real-time PCR, by Country USD Million (2013-2018)
  • Table 68. Europe Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 69. Europe Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 70. Europe Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 71. Europe Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 72. Germany Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 73. Germany Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 74. Germany Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 75. Germany Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 76. France Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 77. France Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 78. France Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 79. France Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 80. Italy Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 81. Italy Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 82. Italy Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 83. Italy Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 84. United Kingdom Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 85. United Kingdom Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 86. United Kingdom Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 87. United Kingdom Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 88. Netherlands Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 89. Netherlands Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 90. Netherlands Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 91. Netherlands Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 92. Rest of Europe Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 93. Rest of Europe Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 94. Rest of Europe Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 95. Rest of Europe Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 96. MEA Digital PCR and Real-time PCR, by Country USD Million (2013-2018)
  • Table 97. MEA Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 98. MEA Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 99. MEA Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 100. MEA Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 101. Middle East Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 102. Middle East Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 103. Middle East Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 104. Middle East Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 105. Africa Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 106. Africa Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 107. Africa Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 108. Africa Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 109. North America Digital PCR and Real-time PCR, by Country USD Million (2013-2018)
  • Table 110. North America Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 111. North America Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 112. North America Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 113. North America Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 114. United States Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 115. United States Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 116. United States Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 117. United States Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 118. Canada Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 119. Canada Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 120. Canada Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 121. Canada Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 122. Mexico Digital PCR and Real-time PCR, by Type USD Million (2013-2018)
  • Table 123. Mexico Digital PCR and Real-time PCR, by Application USD Million (2013-2018)
  • Table 124. Mexico Digital PCR and Real-time PCR, by End-user USD Million (2013-2018)
  • Table 125. Mexico Digital PCR and Real-time PCR, by Solution USD Million (2013-2018)
  • Table 126. Digital PCR and Real-time PCR Sales: by Type(Y)
  • Table 127. Digital PCR and Real-time PCR Sales Instruments , by Region Y (2013-2018)
  • Table 128. Digital PCR and Real-time PCR Sales Reagents , by Region Y (2013-2018)
  • Table 129. Digital PCR and Real-time PCR Sales: by Application(Y)
  • Table 130. Digital PCR and Real-time PCR Sales Clinical [Pathogen Testing, Blood Screening, Oncology Testing, Others] , by Region Y (2013-2018)
  • Table 131. Digital PCR and Real-time PCR Sales Research , by Region Y (2013-2018)
  • Table 132. Digital PCR and Real-time PCR Sales Forensic and Others , by Region Y (2013-2018)
  • Table 133. Digital PCR and Real-time PCR Sales: by End-user(Y)
  • Table 134. Digital PCR and Real-time PCR Sales Hospitals , by Region Y (2013-2018)
  • Table 135. Digital PCR and Real-time PCR Sales Diagnostic Labs , by Region Y (2013-2018)
  • Table 136. Digital PCR and Real-time PCR Sales Academia , by Region Y (2013-2018)
  • Table 137. Digital PCR and Real-time PCR Sales Pharma-Biotech , by Region Y (2013-2018)
  • Table 138. Digital PCR and Real-time PCR Sales CRO , by Region Y (2013-2018)
  • Table 139. Digital PCR and Real-time PCR Sales: by Solution(Y)
  • Table 140. Digital PCR and Real-time PCR Sales Software , by Region Y (2013-2018)
  • Table 141. Digital PCR and Real-time PCR Sales Services , by Region Y (2013-2018)
  • Table 142. South America Digital PCR and Real-time PCR Sales, by Country Y (2013-2018)
  • Table 143. South America Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 144. South America Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 145. South America Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 146. South America Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 147. Brazil Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 148. Brazil Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 149. Brazil Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 150. Brazil Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 151. Argentina Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 152. Argentina Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 153. Argentina Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 154. Argentina Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 155. Rest of South America Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 156. Rest of South America Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 157. Rest of South America Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 158. Rest of South America Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 159. Asia Pacific Digital PCR and Real-time PCR Sales, by Country Y (2013-2018)
  • Table 160. Asia Pacific Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 161. Asia Pacific Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 162. Asia Pacific Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 163. Asia Pacific Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 164. China Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 165. China Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 166. China Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 167. China Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 168. Japan Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 169. Japan Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 170. Japan Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 171. Japan Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 172. India Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 173. India Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 174. India Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 175. India Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 176. South Korea Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 177. South Korea Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 178. South Korea Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 179. South Korea Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 180. Taiwan Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 181. Taiwan Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 182. Taiwan Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 183. Taiwan Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 184. Australia Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 185. Australia Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 186. Australia Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 187. Australia Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 188. Rest of Asia-Pacific Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 189. Rest of Asia-Pacific Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 190. Rest of Asia-Pacific Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 191. Rest of Asia-Pacific Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 192. Europe Digital PCR and Real-time PCR Sales, by Country Y (2013-2018)
  • Table 193. Europe Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 194. Europe Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 195. Europe Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 196. Europe Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 197. Germany Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 198. Germany Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 199. Germany Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 200. Germany Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 201. France Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 202. France Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 203. France Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 204. France Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 205. Italy Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 206. Italy Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 207. Italy Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 208. Italy Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 209. United Kingdom Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 210. United Kingdom Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 211. United Kingdom Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 212. United Kingdom Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 213. Netherlands Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 214. Netherlands Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 215. Netherlands Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 216. Netherlands Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 217. Rest of Europe Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 218. Rest of Europe Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 219. Rest of Europe Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 220. Rest of Europe Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 221. MEA Digital PCR and Real-time PCR Sales, by Country Y (2013-2018)
  • Table 222. MEA Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 223. MEA Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 224. MEA Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 225. MEA Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 226. Middle East Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 227. Middle East Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 228. Middle East Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 229. Middle East Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 230. Africa Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 231. Africa Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 232. Africa Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 233. Africa Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 234. North America Digital PCR and Real-time PCR Sales, by Country Y (2013-2018)
  • Table 235. North America Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 236. North America Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 237. North America Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 238. North America Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 239. United States Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 240. United States Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 241. United States Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 242. United States Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 243. Canada Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 244. Canada Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 245. Canada Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 246. Canada Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 247. Mexico Digital PCR and Real-time PCR Sales, by Type Y (2013-2018)
  • Table 248. Mexico Digital PCR and Real-time PCR Sales, by Application Y (2013-2018)
  • Table 249. Mexico Digital PCR and Real-time PCR Sales, by End-user Y (2013-2018)
  • Table 250. Mexico Digital PCR and Real-time PCR Sales, by Solution Y (2013-2018)
  • Table 251. Digital PCR and Real-time PCR: by Type(USD/Units)
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Digital PCR and Real-time PCR: by Type(USD Million)
  • Table 265. Digital PCR and Real-time PCR Instruments , by Region USD Million (2019-2024)
  • Table 266. Digital PCR and Real-time PCR Reagents , by Region USD Million (2019-2024)
  • Table 267. Digital PCR and Real-time PCR: by Application(USD Million)
  • Table 268. Digital PCR and Real-time PCR Clinical [Pathogen Testing, Blood Screening, Oncology Testing, Others] , by Region USD Million (2019-2024)
  • Table 269. Digital PCR and Real-time PCR Research , by Region USD Million (2019-2024)
  • Table 270. Digital PCR and Real-time PCR Forensic and Others , by Region USD Million (2019-2024)
  • Table 271. Digital PCR and Real-time PCR: by End-user(USD Million)
  • Table 272. Digital PCR and Real-time PCR Hospitals , by Region USD Million (2019-2024)
  • Table 273. Digital PCR and Real-time PCR Diagnostic Labs , by Region USD Million (2019-2024)
  • Table 274. Digital PCR and Real-time PCR Academia , by Region USD Million (2019-2024)
  • Table 275. Digital PCR and Real-time PCR Pharma-Biotech , by Region USD Million (2019-2024)
  • Table 276. Digital PCR and Real-time PCR CRO , by Region USD Million (2019-2024)
  • Table 277. Digital PCR and Real-time PCR: by Solution(USD Million)
  • Table 278. Digital PCR and Real-time PCR Software , by Region USD Million (2019-2024)
  • Table 279. Digital PCR and Real-time PCR Services , by Region USD Million (2019-2024)
  • Table 280. South America Digital PCR and Real-time PCR, by Country USD Million (2019-2024)
  • Table 281. South America Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 282. South America Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 283. South America Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 284. South America Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 285. Brazil Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 286. Brazil Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 287. Brazil Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 288. Brazil Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 289. Argentina Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 290. Argentina Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 291. Argentina Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 292. Argentina Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 293. Rest of South America Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 294. Rest of South America Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 295. Rest of South America Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 296. Rest of South America Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 297. Asia Pacific Digital PCR and Real-time PCR, by Country USD Million (2019-2024)
  • Table 298. Asia Pacific Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 299. Asia Pacific Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 300. Asia Pacific Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 301. Asia Pacific Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 302. China Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 303. China Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 304. China Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 305. China Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 306. Japan Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 307. Japan Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 308. Japan Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 309. Japan Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 310. India Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 311. India Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 312. India Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 313. India Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 314. South Korea Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 315. South Korea Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 316. South Korea Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 317. South Korea Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 318. Taiwan Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 319. Taiwan Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 320. Taiwan Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 321. Taiwan Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 322. Australia Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 323. Australia Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 324. Australia Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 325. Australia Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 326. Rest of Asia-Pacific Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 327. Rest of Asia-Pacific Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 328. Rest of Asia-Pacific Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 329. Rest of Asia-Pacific Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 330. Europe Digital PCR and Real-time PCR, by Country USD Million (2019-2024)
  • Table 331. Europe Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 332. Europe Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 333. Europe Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 334. Europe Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 335. Germany Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 336. Germany Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 337. Germany Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 338. Germany Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 339. France Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 340. France Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 341. France Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 342. France Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 343. Italy Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 344. Italy Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 345. Italy Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 346. Italy Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 347. United Kingdom Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 348. United Kingdom Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 349. United Kingdom Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 350. United Kingdom Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 351. Netherlands Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 352. Netherlands Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 353. Netherlands Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 354. Netherlands Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 355. Rest of Europe Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 356. Rest of Europe Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 357. Rest of Europe Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 358. Rest of Europe Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 359. MEA Digital PCR and Real-time PCR, by Country USD Million (2019-2024)
  • Table 360. MEA Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 361. MEA Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 362. MEA Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 363. MEA Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 364. Middle East Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 365. Middle East Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 366. Middle East Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 367. Middle East Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 368. Africa Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 369. Africa Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 370. Africa Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 371. Africa Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 372. North America Digital PCR and Real-time PCR, by Country USD Million (2019-2024)
  • Table 373. North America Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 374. North America Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 375. North America Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 376. North America Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 377. United States Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 378. United States Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 379. United States Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 380. United States Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 381. Canada Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 382. Canada Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 383. Canada Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 384. Canada Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 385. Mexico Digital PCR and Real-time PCR, by Type USD Million (2019-2024)
  • Table 386. Mexico Digital PCR and Real-time PCR, by Application USD Million (2019-2024)
  • Table 387. Mexico Digital PCR and Real-time PCR, by End-user USD Million (2019-2024)
  • Table 388. Mexico Digital PCR and Real-time PCR, by Solution USD Million (2019-2024)
  • Table 389. Digital PCR and Real-time PCR Sales: by Type(Y)
  • Table 390. Digital PCR and Real-time PCR Sales Instruments , by Region Y (2019-2024)
  • Table 391. Digital PCR and Real-time PCR Sales Reagents , by Region Y (2019-2024)
  • Table 392. Digital PCR and Real-time PCR Sales: by Application(Y)
  • Table 393. Digital PCR and Real-time PCR Sales Clinical [Pathogen Testing, Blood Screening, Oncology Testing, Others] , by Region Y (2019-2024)
  • Table 394. Digital PCR and Real-time PCR Sales Research , by Region Y (2019-2024)
  • Table 395. Digital PCR and Real-time PCR Sales Forensic and Others , by Region Y (2019-2024)
  • Table 396. Digital PCR and Real-time PCR Sales: by End-user(Y)
  • Table 397. Digital PCR and Real-time PCR Sales Hospitals , by Region Y (2019-2024)
  • Table 398. Digital PCR and Real-time PCR Sales Diagnostic Labs , by Region Y (2019-2024)
  • Table 399. Digital PCR and Real-time PCR Sales Academia , by Region Y (2019-2024)
  • Table 400. Digital PCR and Real-time PCR Sales Pharma-Biotech , by Region Y (2019-2024)
  • Table 401. Digital PCR and Real-time PCR Sales CRO , by Region Y (2019-2024)
  • Table 402. Digital PCR and Real-time PCR Sales: by Solution(Y)
  • Table 403. Digital PCR and Real-time PCR Sales Software , by Region Y (2019-2024)
  • Table 404. Digital PCR and Real-time PCR Sales Services , by Region Y (2019-2024)
  • Table 405. South America Digital PCR and Real-time PCR Sales, by Country Y (2019-2024)
  • Table 406. South America Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 407. South America Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 408. South America Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 409. South America Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 410. Brazil Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 411. Brazil Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 412. Brazil Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 413. Brazil Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 414. Argentina Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 415. Argentina Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 416. Argentina Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 417. Argentina Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 418. Rest of South America Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 419. Rest of South America Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 420. Rest of South America Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 421. Rest of South America Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 422. Asia Pacific Digital PCR and Real-time PCR Sales, by Country Y (2019-2024)
  • Table 423. Asia Pacific Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 424. Asia Pacific Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 425. Asia Pacific Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 426. Asia Pacific Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 427. China Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 428. China Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 429. China Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 430. China Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 431. Japan Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 432. Japan Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 433. Japan Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 434. Japan Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 435. India Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 436. India Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 437. India Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 438. India Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 439. South Korea Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 440. South Korea Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 441. South Korea Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 442. South Korea Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 443. Taiwan Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 444. Taiwan Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 445. Taiwan Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 446. Taiwan Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 447. Australia Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 448. Australia Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 449. Australia Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 450. Australia Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 451. Rest of Asia-Pacific Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 452. Rest of Asia-Pacific Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 453. Rest of Asia-Pacific Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 454. Rest of Asia-Pacific Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 455. Europe Digital PCR and Real-time PCR Sales, by Country Y (2019-2024)
  • Table 456. Europe Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 457. Europe Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 458. Europe Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 459. Europe Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 460. Germany Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 461. Germany Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 462. Germany Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 463. Germany Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 464. France Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 465. France Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 466. France Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 467. France Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 468. Italy Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 469. Italy Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 470. Italy Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 471. Italy Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 472. United Kingdom Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 473. United Kingdom Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 474. United Kingdom Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 475. United Kingdom Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 476. Netherlands Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 477. Netherlands Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 478. Netherlands Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 479. Netherlands Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 480. Rest of Europe Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 481. Rest of Europe Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 482. Rest of Europe Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 483. Rest of Europe Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 484. MEA Digital PCR and Real-time PCR Sales, by Country Y (2019-2024)
  • Table 485. MEA Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 486. MEA Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 487. MEA Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 488. MEA Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 489. Middle East Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 490. Middle East Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 491. Middle East Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 492. Middle East Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 493. Africa Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 494. Africa Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 495. Africa Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 496. Africa Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 497. North America Digital PCR and Real-time PCR Sales, by Country Y (2019-2024)
  • Table 498. North America Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 499. North America Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 500. North America Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 501. North America Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 502. United States Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 503. United States Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 504. United States Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 505. United States Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 506. Canada Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 507. Canada Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 508. Canada Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 509. Canada Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 510. Mexico Digital PCR and Real-time PCR Sales, by Type Y (2019-2024)
  • Table 511. Mexico Digital PCR and Real-time PCR Sales, by Application Y (2019-2024)
  • Table 512. Mexico Digital PCR and Real-time PCR Sales, by End-user Y (2019-2024)
  • Table 513. Mexico Digital PCR and Real-time PCR Sales, by Solution Y (2019-2024)
  • Table 514. Digital PCR and Real-time PCR: by Type(USD/Units)
  • Table 515. Research Programs/Design for This Report
  • Table 516. Key Data Information from Secondary Sources
  • Table 517. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Digital PCR and Real-time PCR: by Type USD Million (2013-2018)
  • Figure 5. Global Digital PCR and Real-time PCR: by Application USD Million (2013-2018)
  • Figure 6. Global Digital PCR and Real-time PCR: by End-user USD Million (2013-2018)
  • Figure 7. Global Digital PCR and Real-time PCR: by Solution USD Million (2013-2018)
  • Figure 8. South America Digital PCR and Real-time PCR Share (%), by Country
  • Figure 9. Asia Pacific Digital PCR and Real-time PCR Share (%), by Country
  • Figure 10. Europe Digital PCR and Real-time PCR Share (%), by Country
  • Figure 11. MEA Digital PCR and Real-time PCR Share (%), by Country
  • Figure 12. North America Digital PCR and Real-time PCR Share (%), by Country
  • Figure 13. Global Digital PCR and Real-time PCR: by Type Y (2013-2018)
  • Figure 14. Global Digital PCR and Real-time PCR: by Application Y (2013-2018)
  • Figure 15. Global Digital PCR and Real-time PCR: by End-user Y (2013-2018)
  • Figure 16. Global Digital PCR and Real-time PCR: by Solution Y (2013-2018)
  • Figure 17. South America Digital PCR and Real-time PCR Share (%), by Country
  • Figure 18. Asia Pacific Digital PCR and Real-time PCR Share (%), by Country
  • Figure 19. Europe Digital PCR and Real-time PCR Share (%), by Country
  • Figure 20. MEA Digital PCR and Real-time PCR Share (%), by Country
  • Figure 21. North America Digital PCR and Real-time PCR Share (%), by Country
  • Figure 22. Global Digital PCR and Real-time PCR: by Type USD/Units (2013-2018)
  • Figure 23. Global Digital PCR and Real-time PCR share by Players 2018 (%)
  • Figure 24. Global Digital PCR and Real-time PCR share by Players (Top 3) 2018(%)
  • Figure 25. Global Digital PCR and Real-time PCR share by Players (Top 5) 2018(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2018
  • Figure 29. F. Hoffman-La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. F. Hoffman-La Roche Ltd. (Switzerland) Revenue: by Geography 2018
  • Figure 31. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2018
  • Figure 33. QIAGEN N.V. (Germany) Revenue, Net Income and Gross profit
  • Figure 34. QIAGEN N.V. (Germany) Revenue: by Geography 2018
  • Figure 35. Takara Bio, Inc. (Japan) Revenue, Net Income and Gross profit
  • Figure 36. Takara Bio, Inc. (Japan) Revenue: by Geography 2018
  • Figure 37. Agilent Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Agilent Technologies, Inc. (United States) Revenue: by Geography 2018
  • Figure 39. BioMérieux S.A. (France) Revenue, Net Income and Gross profit
  • Figure 40. BioMérieux S.A. (France) Revenue: by Geography 2018
  • Figure 41. Fluidigm Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 42. Fluidigm Corporation (United States) Revenue: by Geography 2018
  • Figure 43. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 44. Danaher Corporation (United States) Revenue: by Geography 2018
  • Figure 45. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 46. Abbott Laboratories (United States) Revenue: by Geography 2018
  • Figure 47. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 48. Merck KGaA (Germany) Revenue: by Geography 2018
  • Figure 49. Becton Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 50. Becton Dickinson and Company (United States) Revenue: by Geography 2018
  • Figure 51. Global Digital PCR and Real-time PCR: by Type USD Million (2019-2024)
  • Figure 52. Global Digital PCR and Real-time PCR: by Application USD Million (2019-2024)
  • Figure 53. Global Digital PCR and Real-time PCR: by End-user USD Million (2019-2024)
  • Figure 54. Global Digital PCR and Real-time PCR: by Solution USD Million (2019-2024)
  • Figure 55. South America Digital PCR and Real-time PCR Share (%), by Country
  • Figure 56. Asia Pacific Digital PCR and Real-time PCR Share (%), by Country
  • Figure 57. Europe Digital PCR and Real-time PCR Share (%), by Country
  • Figure 58. MEA Digital PCR and Real-time PCR Share (%), by Country
  • Figure 59. North America Digital PCR and Real-time PCR Share (%), by Country
  • Figure 60. Global Digital PCR and Real-time PCR: by Type Y (2019-2024)
  • Figure 61. Global Digital PCR and Real-time PCR: by Application Y (2019-2024)
  • Figure 62. Global Digital PCR and Real-time PCR: by End-user Y (2019-2024)
  • Figure 63. Global Digital PCR and Real-time PCR: by Solution Y (2019-2024)
  • Figure 64. South America Digital PCR and Real-time PCR Share (%), by Country
  • Figure 65. Asia Pacific Digital PCR and Real-time PCR Share (%), by Country
  • Figure 66. Europe Digital PCR and Real-time PCR Share (%), by Country
  • Figure 67. MEA Digital PCR and Real-time PCR Share (%), by Country
  • Figure 68. North America Digital PCR and Real-time PCR Share (%), by Country
  • Figure 69. Global Digital PCR and Real-time PCR: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • Thermo Fisher Scientific, Inc. (United States)
  • F. Hoffman-La Roche Ltd. (Switzerland)
  • Bio-Rad Laboratories, Inc. (United States)
  • QIAGEN N.V. (Germany)
  • Takara Bio, Inc. (Japan)
  • Agilent Technologies, Inc. (United States)
  • BioMérieux S.A. (France)
  • Fluidigm Corporation (United States)
  • Danaher Corporation (United States)
  • Abbott Laboratories (United States)
  • Merck KGaA (Germany)
  • Becton Dickinson and Company (United States)
Additional players considered in the study are as follows:
Promega Corporation (United States) , Eppendorf AG (Germany) , Analytik Jena AG (Germany)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation